Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
Open Access
- 19 October 2013
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 22 (2) , 469-477
Abstract
Preventing chemotherapy-induced nausea and vomiting (CINV) is integral to treatment success in patients with cancer. This analysis was undertaken to assess the relative efficacy and safety of palonosetron versus older 5HT3 RAs in preventing CINV associated with moderately or highly emetogenic chemotherapy.Keywords
This publication has 32 references indexed in Scilit:
- The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)Annals of Oncology, 2012
- Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective studySupportive Care in Cancer, 2011
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2011
- Electrocardiographic findings of palonosetron in cancer patientsSupportive Care in Cancer, 2011
- Comparative clinical effectiveness of various 5-HT3 RA antiemetic regimens on chemotherapy-induced nausea and vomiting associated with hospital and emergency department visits in real world practiceSupportive Care in Cancer, 2011
- Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysisSupportive Care in Cancer, 2010
- Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital settingSupportive Care in Cancer, 2010
- Insight in the prediction of chemotherapy-induced nauseaSupportive Care in Cancer, 2009
- Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settingsSupportive Care in Cancer, 2006
- Incidence of chemotherapy‐induced nausea and emesis after modern antiemeticsCancer, 2004